Viewing Study NCT00283751


Ignite Creation Date: 2025-12-24 @ 11:54 PM
Ignite Modification Date: 2025-12-25 @ 9:49 PM
Study NCT ID: NCT00283751
Status: COMPLETED
Last Update Posted: 2017-01-27
First Post: 2006-01-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Comparison of Insulin Detemir or Insulin Glargine as Add on to Oral Antidiabetic Drugs in Type 2 Diabetes
Sponsor: Novo Nordisk A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module